Roe Matthew T, Li Shuang, Thomas Laine, Wang Tracy Y, Alexander Karen P, Ohman E Magnus, Peterson Eric D
Duke Clinical Research Institute, Durham, NC 27705, USA.
Circ Cardiovasc Qual Outcomes. 2013 May 1;6(3):323-32. doi: 10.1161/CIRCOUTCOMES.113.000120. Epub 2013 May 7.
Early invasive management is recommended for patients with non-ST-segment elevation myocardial infarction (MI), but the incidence of long-term outcomes after early catheterization among older patients and the relationship of revascularization procedures with outcomes in this population have not been described.
Using data from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines (CRUSADE) registry, we linked 19 336 older patients (≥65 years) with non-ST-segment elevation MI found to have significant coronary disease during catheterization and who survived through 30 days posthospital discharge to Medicare/Medicaid data. All-cause mortality, readmission for MI, readmission for stroke, and use of repeat revascularization procedures were tracked for a median of 1181 days. Outcome comparisons were stratified by use of percutaneous coronary intervention (PCI; n=11 766, 60.8%) or coronary artery bypass grafting (n=3515, 18.2%) performed during the index hospitalization and through 30 days postdischarge, as well as by medical management without revascularization (n=4055, 21.0%). During follow-up, ≈17% of patients underwent PCI (most commonly in patients initially treated with PCI), and only 3% of patients underwent coronary artery bypass grafting. Compared with an unadjusted long-term mortality cumulative incidence through 5 years of 50% in the medical management group, mortality was lower in the PCI group (33.5%; adjusted hazard ratio, 0.75; 95% confidence interval, 0.70-0.79) and lowest in the coronary artery bypass grafting group (24.2%; adjusted hazard ratio, 0.52; 95% confidence interval, 0.47-0.57; P<0.001 for 3-way comparisons). The unadjusted cumulative incidence of the composite of death, readmission for MI, or readmission for stroke at 5 years was 62.4%, 44.9%, and 33.0% for medical management, PCI, and coronary artery bypass grafting, respectively.
Older patients with non-ST-segment elevation MI with significant coronary disease face high long-term risks for mortality and nonfatal cardiovascular outcomes after early catheterization that differ by type of revascularization procedure performed. These findings can help guide the design of studies evaluating long-term therapies among elderly post-MI patients.
对于非ST段抬高型心肌梗死(MI)患者,推荐早期侵入性治疗,但老年患者早期导管插入术后长期预后的发生率以及该人群中血运重建手术与预后的关系尚未见报道。
利用美国心脏病学会/美国心脏协会指南早期实施对不稳定型心绞痛患者进行快速风险分层以抑制不良结局(CRUSADE)注册研究的数据,我们将19336例年龄≥65岁、在导管插入术中发现患有严重冠状动脉疾病且出院后存活30天的非ST段抬高型MI老年患者与医疗保险/医疗补助数据相关联。跟踪全因死亡率、MI再入院率、中风再入院率以及重复血运重建手术的使用情况,中位随访时间为1181天。结局比较按首次住院期间及出院后30天内进行经皮冠状动脉介入治疗(PCI;n = 11766,60.8%)或冠状动脉旁路移植术(n = 3515,18.2%),以及未进行血运重建的药物治疗(n = 4055,21.0%)进行分层。在随访期间,约17%的患者接受了PCI(最常见于最初接受PCI治疗的患者),只有3%的患者接受了冠状动脉旁路移植术。与药物治疗组未经调整的5年长期死亡率累积发生率50%相比,PCI组死亡率较低(33.5%;调整后的风险比,0.75;95%置信区间,0.70 - 0.79),冠状动脉旁路移植术组最低(24.2%;调整后的风险比,0.52;95%置信区间,0.47 - 0.57;三组比较P < 0.001)。药物治疗、PCI和冠状动脉旁路移植术在5年时死亡、MI再入院或中风再入院综合结局的未经调整累积发生率分别为62.4%、44.9%和33.0%。
患有严重冠状动脉疾病的非ST段抬高型MI老年患者在早期导管插入术后面临较高的长期死亡风险和非致命心血管结局风险,且这些风险因所进行的血运重建手术类型而异。这些发现有助于指导评估MI后老年患者长期治疗的研究设计。